NCT02590874View on ClinicalTrials.gov

The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

October 31, 2018

Conditions
Mild Cognitive ImpairmentDepression
Interventions
DRUG

Duloxetine

Duloxetine 30 mg per day for 2 weeks. Duloxetine 60 mg per day for 4 months. Duloxetine 30 mg per day for 2 weeks.

DRUG

Placebo

Placebo 30 mg per day for 2 weeks. Placebo 60 mg per day for 4 months. Placebo 30 mg per day for 2 weeks.

Trial Locations (1)

76107

University of North Texas Health Science Center, Fort Worth

All Listed Sponsors
lead

University of North Texas Health Science Center

OTHER

NCT02590874 - The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter